Tyrosine kinase inhibitors alone as a first-line treatment for patients with non-small-cell lung cancer harboring mutant epidermal growth factor receptor

被引：0
|
作者：
Iuchi, T. [1 ]
Shingyoji, M. [2 ]
Itakura, M. [2 ]
Hasegawa, Y. [1 ]
Yoshida, Y. [2 ]
Ikegami, S. [1 ]
Setoguchi, T. [1 ]
Ashinuma, H. [2 ]
机构：
[1] Chiba Canc Ctr Hosp, Neurol Surg, Chiba, Japan
[2] Chiba Canc Ctr Hosp, Respirol, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw383.54
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1254P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?
    Gridelli, Cesare
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (02) : 131 - 132
  • [2] Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors as a first-line treatment for postoperative recurrent and EGFR-mutated non-small-cell lung cancer
    Moriya, Tetsuji
    Hamaji, Masatsugu
    Yoshizawa, Akihiko
    Miyata, Ryo
    Noguchi, Misa
    Tamari, Shigeyuki
    Chiba, Naohisa
    Miyamoto, Hideaki
    Toyazaki, Toshiya
    Tanaka, Satona
    Yamada, Yoshito
    Yutaka, Yojiro
    Nakajima, Daisuke
    Ohsumi, Akihiro
    Menju, Toshi
    Date, Hiroshi
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2022, 34 (03) : 416 - 423
  • [3] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
    Liao, Bin-Chi
    Lee, Jih-Hsiang
    Lin, Chia-Chi
    Chen, Ya-Fang
    Chang, Chin-Hao
    Ho, Chao-Chi
    Shih, Jin-Yuan
    Yu, Chong-Jen
    Yang, James Chih-Hsin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) : 1754 - 1761
  • [4] Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer
    Rosell, Rafael
    Viteri, Santiago
    Angel Molina, Miguel
    Benlloch, Susana
    Taron, Miquel
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (02) : 112 - 120
  • [5] Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2013, 76 (05) : 249 - 257
  • [6] Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer
    De Luca, A.
    Normanno, N.
    CURRENT DRUG TARGETS, 2010, 11 (07) : 851 - 864
  • [7] Cumulative meta-analysis of epidermal growth factor receptor-tyrosine kinase inhibitors as first-line therapy in metastatic non-small-cell lung cancer
    Normando, Savia R. C.
    Cruz, Felipe M.
    del Giglio, Auro
    ANTI-CANCER DRUGS, 2015, 26 (09) : 995 - 1003
  • [8] Drug Resistance in Late-Stage Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer Patients After First-Line Treatment with Tyrosine Kinase Inhibitors
    Lee, Ching-Yi
    Lee, Shih-Wei
    Hsu, Yi-Chiung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [9] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues
    K. Bencardino
    M. Manzoni
    S. Delfanti
    A. Riccardi
    M. Danova
    G. R. Corazza
    Internal and Emergency Medicine, 2007, 2 : 3 - 12
  • [10] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues
    Bencardino, K.
    Manzoni, M.
    Delfanti, S.
    Riccardi, A.
    Danova, M.
    Corazza, G. R.
    INTERNAL AND EMERGENCY MEDICINE, 2007, 2 (01) : 3 - 12
12345